Prescription Only
This is an FDA-approved prescription product. It should only be obtained through licensed healthcare providers and pharmacies. Do not attempt to source through RUO or gray-market channels.
Evidence visual
Oxytocin evidence and risk matrix
advanced researcher fit
Evidence
Tier A
Risk
med high
Regulatory
rx approved
WADA
none
FDA
none
Route
intranasal
Higher-confidence evidence profile, but regulatory and sourcing checks still matter.
Overview
Oxytocin is a neuropeptide acting via oxytocin receptors, widely studied for social/emotional processing effects. Many human trials use 24 IU intranasal as a standard dose. Generally described as having minimal side-effects at common trial doses, but results vary and vulnerable populations require caution. Highest regulatory risk if marketed as therapeutic rather than clinical research context.
Decision path
Where Oxytocin fits in the research path.
Use the evidence and risk profile first, then compare vendors and run the quiz before turning this compound into a protocol decision.
01
Read evidence
02
Check risk
03
Compare options
04
Build plan
Peptide research path
Decide whether Oxytocin belongs in your plan.
Use the quiz before choosing a compound, vendor, or PDF. It routes by goal, experience, budget, safety flags, and monitoring comfort.
Research Details
Neuropeptide acting via oxytocin receptors; widely studied for social/emotional processing.
intranasal, intravenous
Human trials: commonly 24 IU intranasal.
Social cognition, bonding, anxiety modulation effects in research settings.
Acute effects studied within hours post-dose; mixed efficacy across conditions.
Rx product; clinical supervision required.
Generally minimal at trial doses; vulnerable populations require caution.
No uniform interaction map; treat as Rx/clinical research context.
Cost at a glance
No reliable cycle cost estimate yet. We need cleaner listing price and pack-size data before showing a trustworthy number.
Known Interactions
HPG-axis signaling overlap; FDA flags kisspeptin-10 compounding uncertainty.
Information provided for educational and research reference only. Not medical advice. Not for diagnosing, treating, curing, or preventing disease. Products referenced are labeled Research Use Only (RUO) by vendors; not for human or veterinary use.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Personalized peptide routing
Find the right path for Oxytocin.
Take the quiz before choosing a compound, vendor, or PDF. We match your goal, experience, budget, and monitoring comfort to the next best step in the funnel.
- Goal-matched compound and protocol recommendations.
- Budget and sourcing filters before you leave the site.
- PDF unlocks shown after your personalized result.